A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Pfizer
Pfizer
Eli Lilly and Company
BioNTech SE
National Cancer Institute (NCI)
Amgen
Fate Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
RemeGen Co., Ltd.
University of Utah
Rutgers, The State University of New Jersey
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
Cullinan Therapeutics Inc.
Nurix Therapeutics, Inc.
First Affiliated Hospital of Zhejiang University
Peking University Cancer Hospital & Institute
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Amgen
AstraZeneca
Jazz Pharmaceuticals
Eli Lilly and Company
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Fox Chase Cancer Center
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Innovent Biologics (Suzhou) Co. Ltd.
Merck Sharp & Dohme LLC
Novartis
Calithera Biosciences, Inc
Bristol-Myers Squibb
Emory University
Merck Sharp & Dohme LLC
AIDS Malignancy Consortium
Daiichi Sankyo
Gilead Sciences
Incyte Corporation
Tracon Pharmaceuticals Inc.
AbbVie
Takeda
Oncology Institute of Southern Switzerland
Abramson Cancer Center at Penn Medicine
West Virginia University
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
AbbVie